Company: ARTL
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001640334-25-002022
Chunk: 94

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-11-12
Form: 10-Q
Item: Part II, Item 5
Chunk 94
---
 to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. 

Artelo Biosciences, Inc.(Registrant)  Dated: November 12, 2025/s/ Gregory D. GorgasGregory D. GorgasPresident, Chief Executive Officer, and Director(Principal Executive Officer) 

     /s/ Mark Spring  Mark Spring   Chief Financial Officer and Treasurer   (Principal Financial Officer and   Principal Accounting Officer) 

 36